Filter by tags: Australia Canada Rosatom Clear all tag filters
3 news articles found
Medical isotopes are radioactive substances used in various diagnostic and therapeutic procedures to treat various types of cancers and other conditions. They are essential for modern medicine, allowing physicians to visualise and target specific organs, tissues and cells in a patient’s body.
Over more than a decade, personalised medicine using nuclear techniques has been gaining pace, allowing doctors to tailor therapies and treatments to the specific needs and physiology of a patient, and to avoid harm to healthy organs or tissues.
According to Sven Van den Berghe, chief executive of Belgium-based isotope producer PanTera, one technique that has seen significant advances is known as theranostics – the term used to describe the combination of using one radioactive drug to diagnose and a second to deliver therapy to treat the main tumour and any metastatic tumours.
- Source: Nucnet
- Date: Friday, 14 April 2023
- Original article: nucnet.org/news/sector-aims-to-tackle-isotope-supply-problems-as-excitement-grows-over-targeted-therapies-4-4-2023
Nuclear energy, as an asset class, has the potential to report well against a wide range of Environmental, Social and Governance (ESG) data collection and accounting metrics, according to a new report from the Generation IV International Forum (GIF). This should allow nuclear energy to be considered as an investable asset class, thereby allowing nuclear companies and projects to access climate finance.
- Source: World Nuclear News
- Date: Wednesday, 08 September 2021
- Original article: world-nuclear-news.org/Articles/GIF-highlights-nuclear-s-ESG-attributes
Bolivian president Evo Morales said on 19 November that he wanted the nuclear research centre planned for the city of El Alto, near La Paz, to be the biggest in South America.
- Source: NEI Magazine
- Date: Monday, 23 November 2015
- Original article: neimagazine.com/news/newsbolivia-plans-south-americas-biggest-nuclear-centre-4734392